Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction

在急性髓系白血病中，流式细胞术评估疗效优于再生障碍性贫血时的细胞形态学检查，可修正缺乏分子残留病灶标志物的病例，并可作为再生障碍性贫血和诱导治疗后的独立预后指标。